CatalystPit
TerminalPit ConsensusInsidersPoliticiansInstitutionsNewsScreener

MAZEMaze Therapeutics, Inc.

NASDAQ · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Last close $27.18 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Market cap$1.51B
CountryUSA
RECENT INSIDER TRADES
  • 2026-10-02 · Coloma Jason V (Chief Executive Officer) · SELL
  • 2026-10-02 · Bernstein Harold (President, R&D & CMO) · SELL
  • 2026-10-02 · Bernstein Harold (President, R&D & CMO) · OTHER
  • 2026-10-01 · Dandekar Atul (CSBO) · OTHER
INSTITUTIONAL OWNERSHIP
Institutional holders168
Shares held63,142,897
Value$1.81B
Percent of shares outstanding113.67%
As of quarter end2026-06-30
RECENT NEWS
  • Maze Therapeutics to present kidney disease program data at ASN conference
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Maze Therapeutics, Inc. (MAZE) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit